Skip to main content
ICHR $71.05 -0.20%
ICHR logo

ICHR · Ichor Holdings, Ltd.

Track ICHR — free
$71.05 -0.14 (-0.20%) At close · Aug 14
Market Cap
$2.66B
Shares
37.45M
All earnings calls

Earnings call · FY2024 Q2

Ichor Holdings, Ltd. Q2 FY2024 Earnings Call

Ichor Holdings, Ltd. Q2 FY2024 Earnings Call

Concluded Aug 6, 2024
Aug 6, 2024 53 turns
Period
FY2024 Q2
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Silicon carbide / EV gas panel softness 43 WFE demand recovery and second-half outlook 36 Gross margin improvement and operating leverage 27 Next generation gas panel (proprietary products) 26 Guidance and longer-term revenue targets 23 Technology inflections driving WFE intensity 17

Management tone

Confident

Net tone +62 · moderate hedging

Grounding quotes
  • “we are pleased to report solid second quarter results with $203 million of sales near the top end of our forecast, continued sequential improvement in gross margin and EPS of $0.05”
  • “we look forward to ramping revenues back towards the $250 million to $300 million plus level next year”
  • “Our confidence has increased around the strongest second half, largely due to the recent strengthening of the Q4 demand profile”
  • “our silicon carbide gas panel business, which has slowed heading into the second half, is expected to return as a growth driver in 2025”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $203.23M +9.8% YoY
Diluted EPS -$0.15
Gross margin 12.6% -1.3 pp YoY
Net income -$5.11M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

Singapore$81.54M +15.9% YoY
United States$69.26M +12.4% YoY
Other Countries$31.12M +23.3% YoY
Europe$21.31M -23.3% YoY
Full-screen source Call document